Metformin Stada

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Stada (Metformin Hydrochloride)

Q: What is Metformin Stada used for?

Metformin Stada is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus. It helps lower blood glucose by reducing liver glucose production and improving insulin sensitivity.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride acts primarily by inhibiting hepatic gluconeogenesis and enhancing peripheral glucose uptake. This dual action reduces overall blood glucose levels without stimulating insulin secretion.

Q: What is the usual dose of Metformin Stada?

The dose of Metformin Stada is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions.

Q: Is Metformin Stada safe during pregnancy or breastfeeding?

The safety of Metformin Stada in pregnancy or while breastfeeding has not been definitively established. Use only if the potential benefit justifies any potential risk and after consultation with a qualified healthcare provider.

Q: How do I order Metformin Stada from GNH India?

To order Metformin Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformin Stada compare with other antidiabetic drugs?

Metformin belongs to the biguanide class and is often first‑line therapy because it does not cause weight gain and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. It is frequently combined with newer agents such as DPP‑4 inhibitors or SGLT2 inhibitors for additional glucose lowering.

Q: What are the storage and handling requirements for Metformin Stada?

Metformin Stada should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children.

Q: How is Metformin Stada administered?

Metformin Stada is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing or chewing unless specifically advised by a healthcare professional.

Q: What are the most serious risks associated with Metformin Stada?

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, liver disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Q: Who should not use Metformin Stada?

Metformin Stada is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or any component of the formulation.

Metformin Hydrochloride, the active ingredient in Metformin Stada, is a biguanide presented as a oral tablet for oral use. It treats type 2 diabetes mellitus in adults.
GNH India supplies Metformin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Stada is used to manage hyperglycaemia in the type 2 diabetes pathway.

Type 2 diabetes mellitus: improves glycaemic control and lowers HbA1c.
Adjunct to diet and exercise: helps achieve target fasting and post‑prandial glucose levels.
Combination therapy: can be added to other antidiabetic agents to reach individualized glucose goals.

How It Works

Metformin Hydrochloride lowers hepatic glucose production by inhibiting mitochondrial respiratory‑chain complex I, which reduces gluconeogenesis. It also enhances peripheral insulin sensitivity by increasing glucose uptake in muscle and adipose tissue and modestly decreases intestinal glucose absorption, resulting in overall reduced blood glucose concentrations.

Side Effects

Metformin Stada may cause a range of adverse reactions.

Common Side Effects

Nausea: mild to moderate stomach upset.
Diarrhoea: loose stools, often transient.
Abdominal discomfort: cramping or bloating.
Metallic taste: transient alteration of taste.
Weight loss: modest reduction in body weight.
Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects

Lactic acidosis: rare but life‑threatening metabolic acidosis.
Severe skin reactions: such as Stevens‑Johnson syndrome.
Hepatotoxicity: elevated liver enzymes.
Hypoglycaemia: when combined with insulin or sulfonylureas.
Acute pancreatitis: very uncommon.
Anaphylactic reaction: rare hypersensitivity.

Precautions & Warnings

Metformin Stada requires careful monitoring and patient education.

Renal function: assess creatinine clearance before initiation and periodically thereafter.
Hepatic function: avoid use in patients with significant liver disease.
Contraindication: do not use in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Alcohol consumption: limit intake to reduce risk of lactic acidosis.
Elderly patients: start at lower doses and monitor for accumulation.
Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Metformin Stada can interact with several medicines, requiring dose adjustment or monitoring.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
Cimetidine: can raise metformin plasma concentrations.
Alcohol: potentiates lactic acidosis.
Nucleoside reverse transcriptase inhibitors: may increase metformin levels.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycaemia symptoms.
Diuretics: can affect renal clearance of metformin.
ACE inhibitors/ARBs: monitor renal function and potassium.
Warfarin: occasional alteration of INR, require monitoring.
Digoxin: watch for changes in serum levels.

Frequently Asked Questions

Metformin Stada is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus. It helps lower blood glucose by reducing liver glucose production and improving insulin sensitivity.

Metformin Hydrochloride acts primarily by inhibiting hepatic gluconeogenesis and enhancing peripheral glucose uptake. This dual action reduces overall blood glucose levels without stimulating insulin secretion.

The dose of Metformin Stada is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions.

The safety of Metformin Stada in pregnancy or while breastfeeding has not been definitively established. Use only if the potential benefit justifies any potential risk and after consultation with a qualified healthcare provider.

To order Metformin Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy because it does not cause weight gain and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. It is frequently combined with newer agents such as DPP‑4 inhibitors or SGLT2 inhibitors for additional glucose lowering.

Metformin Stada should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children.

Metformin Stada is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing or chewing unless specifically advised by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, liver disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin Stada is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.